(Q43923373)

28 November 2017

In vitro effect of advanced glycation end-products on human polymorphonuclear superoxide production (English)

1 reference

28 November 2017

Bernheim J

1

1 reference

28 November 2017

Rashid G

2

1 reference

28 November 2017

Gavrieli R

3

1 reference

28 November 2017

Korzets Z

4

1 reference

28 November 2017

Wolach B

5

1 reference

28 November 2017

1 December 2001

1 reference

European Journal of Clinical Investigation

28 November 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 November 2017

31

1 reference

28 November 2017

12

1 reference

28 November 2017

1064-1069

1 reference

Role of oxidative stress in development of complications in diabetes

28 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Infections in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Effect of alcohol and various diseases on leukocyte mobilization, phagocytosis and intracellular bacterial killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

The respiratory burst of phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Integrin overexpression induced by high glucose and by human diabetes: potential pathway to cell dysfunction in diabetic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

Advanced glycosylation end products in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00911.X

10.1046/J.1365-2362.2001.00911.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference